Pelage Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Pelage General Information

Description

Provider of regenerative medicines intended to develop clinical-stage treatments for hair loss grounded in stem cell biology. The company offers a topical small molecule program, clinical trials for androgenetic alopecia and other alopecia types, stem cell biology research, a regenerative medicine platform, and press-reported financing information, providing clients with advanced hair loss treatment programs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 907 Westwood Boulevard
  • Suite 384
  • Los Angeles, CA 90024
  • United States
+1 (949)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Corporate Office
  • 907 Westwood Boulevard
  • Suite 384
  • Los Angeles, CA 90024
  • United States
+1 (949)

Pelage Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pelage Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator Completed Generating Revenue
4. Later Stage VC (Series B) 15-Oct-2025 Completed Generating Revenue
3. Later Stage VC (Series A1) 13-Aug-2024 Completed Generating Revenue
2. Later Stage VC (Series A) 27-Feb-2024 $16.7M $16.7M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Pelage’s complete valuation and funding history, request access »

Pelage Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A1
Series A 9,247,498 $0.000100 $1.81 $1.81 1x $1.81 20.69%
To view Pelage’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Pelage Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of regenerative medicines intended to develop clinical-stage treatments for hair loss grounded in stem cell bio
Biotechnology
Los Angeles, CA
10 As of 2026

San Diego, CA
 

CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pelage Competitors (3)

One of Pelage’s 3 competitors is Amplifica (Drug Discovery), a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amplifica (Drug Discovery) Venture Capital-Backed San Diego, CA
Stemsontx Venture Capital-Backed CA
Yuva Biosciences Venture Capital-Backed Birmingham, AL
You’re viewing 3 of 3 competitors. Get the full list »

Pelage Patents

Pelage Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4642783-A1 Compounds for treatment of hair loss Pending 27-Dec-2022
US-20260207566-A1 Compounds for treatment of hair loss Pending 27-Dec-2022
WO-2024145369-A1 Compounds for treatment of hair loss Inactive 27-Dec-2022
AU-2022424022-A1 Compounds for treatment of hair loss Pending 29-Dec-2021
AU-2022425460-A1 Compounds for treatment of hair loss Pending 29-Dec-2021 C07D471/04
To view Pelage’s complete patent history, request access »

Pelage Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pelage Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARCH Venture Partners Venture Capital Minority
Hawktail Venture Capital Minority
Novo Holdings Venture Capital Minority
GV Corporate Venture Capital Minority
Main Street Advisors PE/Buyout Minority
You’re viewing 5 of 9 investors. Get the full list »

Pelage FAQs

  • When was Pelage founded?

    Pelage was founded in 2018.

  • Where is Pelage headquartered?

    Pelage is headquartered in Los Angeles, CA.

  • What is the size of Pelage?

    Pelage has 10 total employees.

  • What industry is Pelage in?

    Pelage’s primary industry is Biotechnology.

  • Is Pelage a private or public company?

    Pelage is a Private company.

  • What is Pelage’s current revenue?

    The current revenue for Pelage is .

  • How much funding has Pelage raised over time?

    Pelage has raised $151M.

  • Who are Pelage’s investors?

    ARCH Venture Partners, Hawktail, Novo Holdings, GV, and Main Street Advisors are 5 of 9 investors who have invested in Pelage.

  • Who are Pelage’s competitors?

    Amplifica (Drug Discovery), Stemsontx, and Yuva Biosciences are competitors of Pelage.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process